AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...
Starting your investing journey can feel overwhelming, but it doesn’t have to be. Today’s best online brokers for beginners are designed to simplify the process from opening your first account to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results